Terminated NA INTERVENTIONAL 1-arm NCT02101463

MOSTEGRA TRIAL:MO-(Dified) STE-(nt) GRA(-ft): Surgeon-modified Fenestrated-branched Stent-grafts (MOSTEGRA)

Surgeon-Modified Fenestrated/Branched Stent-Grafts for Treatment of Complex Aortic Aneurysms in High-Risk Patients

Sponsor: Northside Hospital, Inc.

Interventions surgeon-modified fenestrated-branched stent-grafts (sm-FBSG)

Updated 7 times since 2017 Last updated: Nov 13, 2019 Started: Aug 28, 2012 Primary completion: Jul 31, 2015 Completion: Dec 8, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Principal Investigator left the organization and took the IDE/Study with him

Other terminated trials from Northside Hospital, Inc.

More terminations from Northside Hospital, Inc.

Listed as NCT02101463, this NA trial focuses on Complex Aortic Aneurysms and remains terminated or withdrawn. Sponsored by Northside Hospital, Inc., it has been updated 7 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Dec 2019 — Jan 2021 [monthly]

Terminated NA

Status: Recruiting → Terminated
Jun 2018 — Dec 2019 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Northside Hospital, Inc.

Data source: Northside Hospital, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Atlanta, United States